Microbial metabolite trimethylamine-N-oxide facilitates colorectal inflammation-cancer transformation by blocking lysosomal degradation of Wnt signaling. [PDF]
Yang K +5 more
europepmc +1 more source
Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study. [PDF]
Lei Y +14 more
europepmc +1 more source
Trimethylamine N-Oxide Linking Gut Microbiota to Cardiocerebral Disease Is a Novel Biomarker for Stroke Subtypes With Mixed Etiology: A Prospective Cohort Study. [PDF]
Wang Y +9 more
europepmc +1 more source
Diabetic cardiomyopathy from a gut microbiota perspective: research progress and prospects. [PDF]
Liang Y, Gao Y, Wang W, Zhao Z.
europepmc +1 more source
Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic kidney disease complications. [PDF]
Lei Y +10 more
europepmc +1 more source
Dietary Fatty Acids Modulate Gut Microbiota-Derived Trimethylamine-N-Oxide: Potential Mechanisms and Future Perspective. [PDF]
Kilic E, Basaran P.
europepmc +1 more source
Correlations Between Trimethylamine-N-Oxide, Megalin, Lysine and Markers of Tubular Damage in Chronic Kidney Disease. [PDF]
Kapetanaki S +8 more
europepmc +1 more source
Gut microbiota-derived trimethylamine N-oxide exacerbates diabetic nephropathy by promoting renal fibrosis. [PDF]
Song YJ +6 more
europepmc +1 more source
Dietary choline-derived Trimethylamine N-oxide impairs hippocampal neuronal function via PANoptosis activation. [PDF]
Wang Y +12 more
europepmc +1 more source

